IL23R Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q5VWK5 |
---|---|
Clone Names | 100507197 |
Gene ID | 149233 |
---|---|
Other Names | Interleukin-23 receptor, IL-23 receptor, IL-23R, IL23R |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | IL23R |
---|---|
Function | Associates with IL12RB1 to form the interleukin-23 receptor. Binds IL23 and mediates T-cells, NK cells and possibly certain macrophage/myeloid cells stimulation probably through activation of the Jak-Stat signaling cascade. IL23 functions in innate and adaptive immunity and may participate in acute response to infection in peripheral tissues. IL23 may be responsible for autoimmune inflammatory diseases and be important for tumorigenesis. |
Cellular Location | Cell membrane; Single-pass type I membrane protein |
Tissue Location | Expressed by monocytes, Th1, Th0, NK and dendritic cells. Isoform 1 is specifically expressed in NK cells |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The protein encoded by this gene is a subunit of thereceptor for IL23A/IL23. This protein pairs with the receptormolecule IL12RB1/IL12Rbeta1, and both are required for IL23Asignaling. This protein associates constitutively with Janus kinase2 (JAK2), and also binds to transcription activator STAT3 in aligand-dependent manner.
References
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Chen, J., et al. Mol. Carcinog. 49(10):862-868(2010)Mizuki, N., et al. Nat. Genet. 42(8):703-706(2010)Remmers, E.F., et al. Nat. Genet. 42(8):698-702(2010)Elmaagacli, A.H., et al. Bone Marrow Transplant. (2010) In press :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.